original article 
Meeting of the American Heart Association
November 4, 2012 | M.E. Farkouh and Others
(DOI: 10.1056/NEJMoa1211585)
(DOI: 10.1056/NEJMoa1211585)
In this trial, patients with diabetes and multivessel coronary disease had a lower risk of MI and death if they were treated with CABG, as compared with coronary stenting with drug-eluting stents. However, the CABG group had an increased risk of stroke.
- Comments
editorial
November 4, 2012 | M.A. Hlatky
(DOI: 10.1056/NEJMe1212278)
(DOI: 10.1056/NEJMe1212278)
medicine and society
November 1, 2012 | L. Rosenbaum
- Free Full Text
perspective
October 31, 2012 | K. Baicker and H. Levy
(DOI: 10.1056/NEJMp1210789)
(DOI: 10.1056/NEJMp1210789)
perspective
October 31, 2012 | P.J. Neumann and J.D. Chambers
(DOI: 10.1056/NEJMp1208386)
(DOI: 10.1056/NEJMp1208386)
Fungal Meningitis Outbreak
The CDC and the FDA are investigating an outbreak among patients who received potentially contaminated therapeutic agents.
original article
Meeting of the American Society of Nephrology
November 3, 2012 | V.E. Torres and Others
(DOI: 10.1056/NEJMoa1205511)
(DOI: 10.1056/NEJMoa1205511)
In this trial, patients with autosomal dominant polycystic kidney disease were randomly assigned to tolvaptan, a vasopressin V2-receptor antagonist, or placebo. Over 3 years, the increase in total kidney volume in the tolvaptan group was half that in the placebo group.
The following papers were published to coincide with presentations at a meeting of the American Heart Association, November 3–7, 2012.
original article
November 4, 2012 | T.A. Brighton and Others
(DOI: 10.1056/NEJMoa1210384)
(DOI: 10.1056/NEJMoa1210384)
- Comments
original article
November 4, 2012 | J.-P. Collet and Others
(DOI: 10.1056/NEJMoa1209979)
(DOI: 10.1056/NEJMoa1209979)
ICMJE Seeks New Members
The International Committee of Medical Journal Editors is expanding its membership. See details.
.png)
No hay comentarios:
Publicar un comentario